PCORI approves $48.5 million to fund new research and projects to speed uptake of evidence into practice

(Patient-Centered Outcomes Research Institute) PCORI Board approves $48.5 million to fund new comparative clinical effectiveness research on second-line medications for Type 2 diabetes and several rare diseases. The Board approved another $5.8 million for four projects to facilitate adoption of useful findings from completed research in clinical care. PCORI also will issue new funding announcements on maternal health, urinary incontinence and mental health among people with intellectual and deve...